Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2012

Open Access 01-12-2012 | Case report

Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report

Authors: Arjuna Mahinda Imbuldeniya, Natasha Jiwa, John Paul Murphy

Published in: Journal of Medical Case Reports | Issue 1/2012

Login to get access

Abstract

Introduction

Atypical insufficiency fractures of the femur in patients on long-term bisphosphonate therapy have been well described in recent literature. The majority of cases are associated with minimal or no trauma and occur in the subtrochanteric or diaphyseal region.

Case presentation

We describe the case of a 76-year-old British Caucasian woman who presented initially to an emergency department and then to her primary care physician with a long-standing history of bilateral knee pain after minor trauma. Plain radiographs showed subtle linear areas of sclerosis bilaterally in her proximal tibiae. Magnetic resonance imaging confirmed the presence of insufficiency fractures in these areas along with her left distal femur. There are very few reports of atypical insufficiency fractures involving the tibia in patients on long-term bisphosphonate therapy and this appears to be the only documented bilateral case involving the metaphyseal regions of the proximal tibia and distal femur.

Conclusion

In addition to existing literature describing atypical fractures in the proximal femur and femoral shaft, there is a need for increased awareness that these fractures can also occur in other weight-bearing areas of the skeleton. All clinicians involved in the care of patients taking long-term bisphosphonates need to be aware of the growing association between new onset lower limb pain and atypical insufficiency fractures.
Appendix
Available only for authorised users
Literature
1.
go back to reference Capeci CM, Tejwani NC: Bilateral low energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009, 91: 2556-2561. 10.2106/JBJS.H.01774.CrossRefPubMed Capeci CM, Tejwani NC: Bilateral low energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009, 91: 2556-2561. 10.2106/JBJS.H.01774.CrossRefPubMed
2.
go back to reference Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS: Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007, 89: 349-353. 10.1302/0301-620X.89B3.18146.CrossRefPubMed Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS: Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007, 89: 349-353. 10.1302/0301-620X.89B3.18146.CrossRefPubMed
3.
go back to reference Neviaser AS, Lane JM, Lenart BA, Edobor-Osula E, Lorich DG: Low energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008, 22: 346-350. 10.1097/BOT.0b013e318172841c.CrossRefPubMed Neviaser AS, Lane JM, Lenart BA, Edobor-Osula E, Lorich DG: Low energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008, 22: 346-350. 10.1097/BOT.0b013e318172841c.CrossRefPubMed
4.
go back to reference Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY: Severely suppressed bone turnover; a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005, 90: 1294-1301.CrossRefPubMed Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY: Severely suppressed bone turnover; a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005, 90: 1294-1301.CrossRefPubMed
5.
go back to reference Cheung RK, Leung KK, Lee KC, Chow TC: Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate. Hong Kong Med J. 2007, 13: 485-489.PubMed Cheung RK, Leung KK, Lee KC, Chow TC: Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate. Hong Kong Med J. 2007, 13: 485-489.PubMed
6.
go back to reference Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM: Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Oseoporosis Int. 2009, 20: 1353-1362. 10.1007/s00198-008-0805-x.CrossRef Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM: Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Oseoporosis Int. 2009, 20: 1353-1362. 10.1007/s00198-008-0805-x.CrossRef
7.
go back to reference Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R: Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital. Drug Saf. 2009, 32: 775-785. 10.2165/00002018-200932090-00002.CrossRefPubMed Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R: Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital. Drug Saf. 2009, 32: 775-785. 10.2165/00002018-200932090-00002.CrossRefPubMed
8.
go back to reference Tonino RP, Meunier PJ, Emkey R, Rodriquez-Portales JA, Menkes CJ, Wasnich RD, Bone HG, Santora AC, Wu M, Desai R, Ross PD: Skeletal benefits of alendronate: 7 year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab. 2000, 85 (9): 3109-3115. 10.1210/jc.85.9.3109.PubMed Tonino RP, Meunier PJ, Emkey R, Rodriquez-Portales JA, Menkes CJ, Wasnich RD, Bone HG, Santora AC, Wu M, Desai R, Ross PD: Skeletal benefits of alendronate: 7 year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab. 2000, 85 (9): 3109-3115. 10.1210/jc.85.9.3109.PubMed
9.
go back to reference Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB: Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone. 2001, 8 (5): 524-531.CrossRef Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB: Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone. 2001, 8 (5): 524-531.CrossRef
10.
go back to reference Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB: Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces biomechanical properties in dog rib. J Bone Miner Res. 2000, 15: 613-620.CrossRefPubMed Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB: Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces biomechanical properties in dog rib. J Bone Miner Res. 2000, 15: 613-620.CrossRefPubMed
11.
go back to reference Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S: Bisphosphonate-induced osteopetrosis. N Engl J Med. 2003, 349: 457-463. 10.1056/NEJMoa023110.CrossRefPubMed Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S: Bisphosphonate-induced osteopetrosis. N Engl J Med. 2003, 349: 457-463. 10.1056/NEJMoa023110.CrossRefPubMed
12.
go back to reference Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC: Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Eng J Med. 2010, 362 (19): 1761-1771. 10.1056/NEJMoa1001086.CrossRef Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC: Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Eng J Med. 2010, 362 (19): 1761-1771. 10.1056/NEJMoa1001086.CrossRef
13.
go back to reference Kewk EB, Goh SK, Koh JS, Png MA, Howe TS: An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?. Injury. 2008, 39: 224-231. 10.1016/j.injury.2007.08.036.CrossRef Kewk EB, Goh SK, Koh JS, Png MA, Howe TS: An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?. Injury. 2008, 39: 224-231. 10.1016/j.injury.2007.08.036.CrossRef
14.
go back to reference Visekruna M, Wilson D, McKiernan FE: Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab. 2008, 93: 2948-2952. 10.1210/jc.2007-2803.CrossRefPubMed Visekruna M, Wilson D, McKiernan FE: Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab. 2008, 93: 2948-2952. 10.1210/jc.2007-2803.CrossRefPubMed
15.
go back to reference Breglia MD, Carter J: Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy. J Clin Rheum. 2010, 16 (2): 76-78. 10.1097/RHU.0b013e3181cf3e3d.CrossRef Breglia MD, Carter J: Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy. J Clin Rheum. 2010, 16 (2): 76-78. 10.1097/RHU.0b013e3181cf3e3d.CrossRef
16.
go back to reference Odvina CV, Levy S, Rao S, Zerwekh JE, Rao DS: Unusual mid shaft fractures during long term bisphosphonate therapy. Clin Endocrinol. 2010, 72 (2): 161-168. 10.1111/j.1365-2265.2009.03581.x.CrossRef Odvina CV, Levy S, Rao S, Zerwekh JE, Rao DS: Unusual mid shaft fractures during long term bisphosphonate therapy. Clin Endocrinol. 2010, 72 (2): 161-168. 10.1111/j.1365-2265.2009.03581.x.CrossRef
17.
go back to reference Giusti A, Hamdy NAT, Papapoulos SE: Atypical fractures of the femur and bisphosphonate therapy. A systematic review of case/case series studies. Bone. 2010, 47: 169-180. 10.1016/j.bone.2010.05.019.CrossRefPubMed Giusti A, Hamdy NAT, Papapoulos SE: Atypical fractures of the femur and bisphosphonate therapy. A systematic review of case/case series studies. Bone. 2010, 47: 169-180. 10.1016/j.bone.2010.05.019.CrossRefPubMed
18.
go back to reference Van Staa TP, Geusens P, Pols HA, de Laet C, Leufkens HG, Cooper C: A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM. 2005, 98: 191-198. 10.1093/qjmed/hci029.CrossRefPubMed Van Staa TP, Geusens P, Pols HA, de Laet C, Leufkens HG, Cooper C: A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM. 2005, 98: 191-198. 10.1093/qjmed/hci029.CrossRefPubMed
19.
go back to reference Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton LJ: A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004, 19: 893-899. 10.1359/JBMR.040134.CrossRefPubMed Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton LJ: A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004, 19: 893-899. 10.1359/JBMR.040134.CrossRefPubMed
20.
go back to reference Degueker J, Maenaut K, Verwilghen J: Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol. 1995, 12: S21-S26. Degueker J, Maenaut K, Verwilghen J: Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol. 1995, 12: S21-S26.
21.
go back to reference Meier L, van Tuyll van Sersooskerken AM, Liberton E, Kleijn L, Westgeest T, Polak M, Nijs R: Fractures of the proximal tibia associated with longterm use of methotrexate: 3 case reports and a review of the literature. J Rheumatol. 2010, 37 (11): 2434-2438. 10.3899/jrheum.100385.CrossRefPubMed Meier L, van Tuyll van Sersooskerken AM, Liberton E, Kleijn L, Westgeest T, Polak M, Nijs R: Fractures of the proximal tibia associated with longterm use of methotrexate: 3 case reports and a review of the literature. J Rheumatol. 2010, 37 (11): 2434-2438. 10.3899/jrheum.100385.CrossRefPubMed
22.
go back to reference Stephen AB, Wallace WA: The management of osteoporosis. J Bone Joint Surg Br. 2001, 83: 316-323. 10.1302/0301-620X.83B3.12196.CrossRefPubMed Stephen AB, Wallace WA: The management of osteoporosis. J Bone Joint Surg Br. 2001, 83: 316-323. 10.1302/0301-620X.83B3.12196.CrossRefPubMed
23.
go back to reference Patel VC, Lazzarini AM: Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use. Orthopaedics. 2010, 33 (10): 775- Patel VC, Lazzarini AM: Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use. Orthopaedics. 2010, 33 (10): 775-
24.
go back to reference Yochum TR, Rowe LJ: Yochum and Rowe's Essentials of Skeletal Radiology. 2004, Philadelphia: Lippincott Williams and Wilkins, 1511-1514. 3 Yochum TR, Rowe LJ: Yochum and Rowe's Essentials of Skeletal Radiology. 2004, Philadelphia: Lippincott Williams and Wilkins, 1511-1514. 3
Metadata
Title
Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report
Authors
Arjuna Mahinda Imbuldeniya
Natasha Jiwa
John Paul Murphy
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2012
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-6-50

Other articles of this Issue 1/2012

Journal of Medical Case Reports 1/2012 Go to the issue